Form 4 for CAH Cardinal Health
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0000721371-23-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-17 | 2023-08-16 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | A - Grant | $0.00 | +15.5K | 44.2K | +54% | $0 | |
| 2023-08-17 | 2023-08-15 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | F - Tax | $92.99 | -11.0K | 28.7K | -28% | -$1.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-16 | A | A | 15,487 | $0.00 | 44,202 | D | — | — | |
| 2 | Common | Common Shares | 2023-08-15 | F | D | 10,966 | $92.99 | 28,715 | D | — | — | (F2) Reflects closing price on prior business day. |